de Weger RA - Search Results

1

Identification of human ccn2 (connective tissue growth factor) promoter polymorphisms.

Blom IE, van Dijk AJ, de Weger RA, Tilanus MG, Goldschmeding R. Blom IE, et al. Among authors: de weger ra. Mol Pathol. 2001 Jun;54(3):192-6. doi: 10.1136/mp.54.3.192. Mol Pathol. 2001. PMID: 11376134 Free PMC article.

2

Donor interleukin-4 promoter gene polymorphism influences allograft rejection after heart transplantation.

Bijlsma FJ, vanKuik J, Tilanus MG, deJonge N, Rozemuller EH, van den Tweel JG, Gmelig-Meyling FH, deWeger RA. Bijlsma FJ, et al. J Heart Lung Transplant. 2002 Mar;21(3):340-6. doi: 10.1016/s1053-2498(01)00386-2. J Heart Lung Transplant. 2002. PMID: 11897522

3

No association between transforming growth factor beta gene polymorphism and acute allograft rejection after cardiac transplantation.

Bijlsma FJ, van der Horst AA, Tilanus MG, Rozemuller E, de Jonge N, Gmelig-Meyling FH, de Weger RA. Bijlsma FJ, et al. Among authors: de jonge n, de weger ra. Transpl Immunol. 2002 Jun;10(1):43-7. doi: 10.1016/s0966-3274(02)00021-7. Transpl Immunol. 2002. PMID: 12182464

4

No association between IL-10 promoter gene polymorphism and heart failure or rejection following cardiac transplantation.

Bijlsma FJ, Bruggink AH, Hartman M, Gmelig-Meyling FH, Tilanus MG, de Jonge N, de Weger RA. Bijlsma FJ, et al. Among authors: de jonge n, de weger ra. Tissue Antigens. 2001 Feb;57(2):151-3. doi: 10.1034/j.1399-0039.2001.057002151.x. Tissue Antigens. 2001. PMID: 11260510

5

Acute cardiac transplant rejection is associated with low frequencies of interleukin-4 producing helper T-lymphocytes rather than with interleukin-4 promoter or splice variants.

Bijlsma FJ, van Kuik J, van Hoffen E, de Jonge N, Tilanus MG, Gmelig-Meyling FH, de Weger RA. Bijlsma FJ, et al. Among authors: de jonge n, de weger ra. Hum Immunol. 2002 Apr;63(4):317-23. doi: 10.1016/s0198-8859(02)00370-1. Hum Immunol. 2002. PMID: 12039414

6

Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.

Van der Velde-Zimmermann D, Roijers JF, Bouwens-Rombouts A, De Weger RA, De Graaf PW, Tilanus MG, Van den Tweel JG. Van der Velde-Zimmermann D, et al. Among authors: de graaf pw, de weger ra. Am J Pathol. 1996 Sep;149(3):759-64. Am J Pathol. 1996. PMID: 8780380 Free PMC article.

7

Cytokine messenger RNA expression by donor-specific cytotoxic T-cell clones after allogeneic heart transplantation.

Van Hoffen E, Gmelig-Meyling FH, Bosboom-Kalsbeek KC, Hu H, De Jonge N, Tilanus MG, Lahpor JR, De Weger RA. Van Hoffen E, et al. Among authors: de jonge n, de weger ra. J Heart Lung Transplant. 1997 Feb;16(2):216-21. J Heart Lung Transplant. 1997. PMID: 9059933

8

Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.

Kropveld A, Rozemuller EH, Leppers FG, Scheidel KC, de Weger RA, Koole R, Hordijk GJ, Slootweg PJ, Tilanus MG. Kropveld A, et al. Among authors: de weger ra. Lab Invest. 1999 Mar;79(3):347-53. Lab Invest. 1999. PMID: 10092071

9

An alternatively spliced interleukin 4 form in lymphoid cells.

Klein SC, Golverdingen JG, Bouwens AG, Tilanus MG, de Weger RA. Klein SC, et al. Among authors: de weger ra. Immunogenetics. 1995;41(1):57. doi: 10.1007/BF00188440. Immunogenetics. 1995. PMID: 7806280 No abstract available.

10

Expression of T-cell receptor alpha and beta variable genes in normal and malignant human T cells.

Hu H, Queirò MR, Tilanus MG, de Weger RA, Schuurman HJ. Hu H, et al. Among authors: de weger ra. Br J Haematol. 1993 May;84(1):39-48. doi: 10.1111/j.1365-2141.1993.tb03023.x. Br J Haematol. 1993. PMID: 8338778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters